December 19, 2017 / 5:42 PM / 7 months ago

BRIEF-Theradiag Provides Update On Prestizia And Its Partnership With HOB Biotech

Dec 19 (Reuters) - THERADIAG SA:

* DISCONTINUATION OF ITS PRESTIZIA RESEARCH ACTIVITY, A WHOLLY-OWNED SUBSIDIARY OF THERADIAG‍​

* SAYS CONTRACTS RENEGOTIATION DISCUSSIONS INITIATED BY HOB BIOTECH REACHED AN IMPASSE

* SAYS IT’S NOT POSSIBLE AT THIS STAGE TO ANTICIPATE CONSEQUENCES OF SITUATION ON HOB BIOTECH PARTNERSHIP

* SAYS IT’S NOT POSSIBLE AT THIS STAGE TO ANTICIPATE CONSEQUENCES OF SITUATION ON LAUNCH OF BIOCLIA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below